Collegium Pharmaceutical (COLL) Current Deferred Revenue (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Current Deferred Revenue of $667000.0 for Q1 2026, down 97.63% year-over-year from $28.1 million in Q1 2025, and little changed quarter-over-quarter from $667000.0 in Q4 2025.
Collegium Pharmaceutical (COLL) Current Deferred Revenue (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Current Deferred Revenue history runs 10 years deep, the most recent figure standing at $667000.0 for Q1 2026.
- In Q1 2026, Current Deferred Revenue fell 97.63% year-over-year to $667000.0; the TTM figure through Mar 2026 stood at $667000.0 (down 97.63% YoY), while the FY2025 annual figure was $667000.0, down 99.55% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $667000.0, roughly flat from $667000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $167.5 million in Q3 2023, with the low at $667000.0 in Q3 2025.
- The 5-year median for Current Deferred Revenue is $51.3 million (2022), against an average of $68.0 million.
- The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue soared 89.84% in 2024, then sank 99.55% in 2025.
- Collegium Pharmaceutical's Current Deferred Revenue stood at $73.6 million in 2022, then grew by 5.37% to $77.5 million in 2023, then soared by 89.84% to $147.1 million in 2024, then tumbled by 99.55% to $667000.0 in 2025, then changed by 0.0% to $667000.0 in 2026.
- Business Quant data shows COLL's Current Deferred Revenue at $667000.0 in Q1 2026, $667000.0 in Q4 2025, and $667000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Collegium Pharmaceutical | 897.54 Mn | 748.22 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 667,000.00 |
| Mar 31, 2026 | 667,000.00 |
| Dec 31, 2025 | 667,000.00 |
| Sep 30, 2025 | 667,000.00 |
| Jun 30, 2025 | 28.95 Mn |
| Mar 31, 2025 | 28.12 Mn |
| Dec 31, 2024 | 147.13 Mn |
| Sep 30, 2024 | 116.03 Mn |
| Jun 30, 2024 | 155.17 Mn |
| Mar 31, 2024 | 20.63 Mn |
| Dec 31, 2023 | 77.51 Mn |
| Sep 30, 2023 | 167.49 Mn |
| Dec 31, 2022 | 73.55 Mn |
| Dec 31, 2021 | 142.38 Mn |
| Jun 30, 2017 | 10.36 Mn |
| Mar 31, 2017 | 8.70 Mn |
| Dec 31, 2016 | 4.94 Mn |
| Sep 30, 2016 | 3.94 Mn |
| Jun 30, 2016 | 3.93 Mn |
| Jun 30, 2015 | 30,000.00 |